Resapp Health Stock

Resapp Health Enterprise Value

The Enterprise Value (EV) of Resapp Health (RAP.AX) as of Sep 5, 2026 is 30.17 M AUD. In the previous year, Enterprise Value (EV) was 26.14 M AUD — a change of 15.43% (higher).

Enterprise Value

30.17 MAUD

YoY

15.43%

Last updated:

Enterprise Value (EV) of Resapp Health is 2026 30.17 M AUD. Enterprise Value (EV) of Resapp Health was 2025 26.14 M AUD. It decreases by 15.43% higher compared to the previous year.

The Resapp Health Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2015
28.44 M AUD
Jan 1, 2016
18.80 M AUD
Jan 1, 2017
23.98 M AUD
Jan 1, 2018
29.14 M AUD
Jan 1, 2019
27.02 M AUD
Jan 1, 2020
27.09 M AUD
Jan 1, 2021
26.14 M AUD
Jan 1, 2022
30.17 M AUD
The Resapp Health Enterprise Value history
YEAREnterprise ValueYoY
30.17 MAUD+15.43%
26.14 MAUD-3.51%
27.09 MAUD+0.26%
27.02 MAUD-7.27%
29.14 MAUD+21.50%
23.98 MAUD+27.55%
18.80 MAUD-33.89%
28.44 MAUD-12.48%
32.50 MAUD
Access this data via the Eulerpool API

Resapp Health Stock analysis

What does Resapp Health do? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Resapp Health stock

Enterprise Value (EV) of Resapp Health is 30.17 M AUD in 2026.

Enterprise Value (EV) of Resapp Health changed from 26.14 M AUD to 30.17 M AUD, representing a 15.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Resapp Health since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s AUD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' AUD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Resapp Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Resapp Health

All Key Metrics — Resapp Health